One notable trend is the increasing adoption of NGS in non-invasive prenatal testing (NIPT). NGS allows for comprehensive analysis of fetal DNA obtained from maternal blood, offering accurate screening for chromosomal abnormalities. The widespread adoption of NIPT presents significant growth opportunities for NGS-based diagnostics.
Another emerging trend is the integration of NGS with artificial intelligence (AI) and machine learning (ML) algorithms. AI-powered NGS data analysis tools can enhance variant calling, improve genomic annotation, and streamline the interpretation of sequencing data. The combination of NGS and AI/ML has the potential to accelerate research discoveries and enhance clinical decision-making.
Furthermore, the application of Next Generation Sequencing Market in liquid biopsies is gaining momentum. Liquid biopsies enable the detection and monitoring of circulating tumor DNA and other biomarkers, providing a non-invasive method for cancer diagnosis, treatment monitoring, and early detection of recurrence.
Additionally, the expansion of NGS into emerging markets and the integration of NGS into point-of-care settings are expected to unlock new growth opportunities. The increasing demand for rapid and affordable sequencing solutions in resource-limited settings and decentralized healthcare settings creates avenues for market expansion.
Read More,
https://cmiinfopiece.blogspot.com/2023/06/next-generation-sequencing-market.html
Comments
0 comment